A positive correlation between SLC7A11 expression and malignant tumor progression is shown in Figure 9F, and survival analysis indicated that compared to the high expression of SLC7A11, low expression of SLC7A11 led to a higher survival probability in both ICGC and TCGA‐LIHC cohort (Figure 9G,H). The gene discussed is SLC7A11; the disease is cancer.